Sökning: WFRF:(Dahlström A) > Seattle Heart Failu...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06210naa a2200721 4500 | |
001 | oai:gup.ub.gu.se/254666 | |
003 | SwePub | |
008 | 240528s2017 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:liu-138236 | |
009 | oai:prod.swepub.kib.ki.se:135854880 | |
024 | 7 | a https://gup.ub.gu.se/publication/2546662 URI |
024 | 7 | a https://doi.org/10.1016/j.jacc.2017.03.5682 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1382362 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1358548802 URI |
040 | a (SwePub)gud (SwePub)liud (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Bilchick, K. C.u University of Virginia Health Syst, VA USA4 aut |
245 | 1 0 | a Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators |
264 | 1 | b Elsevier BV,c 2017 |
500 | a Funding Agencies|Thoratec (St. Jude Medical); HeartWare (Medtronic); GE Healthcare; Athena Health; National Institutes of Health [R03 HL135463]; National Cardiovascular Data Registry; National Institute on Aging [K23AG048331]; American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; Yale Claude D. Pepper Older Americans Independence Center [P30AG021342]; Centers for Medicare & Medicaid Services; Boston Scientific; AstraZeneca; Novartis; Servier; Amgen; Resmed | |
520 | a BACKGROUND Recent clinical trials highlight the need for better models to identify patients at higher risk of sudden death. OBJECTIVES The authors hypothesized that the Seattle Heart Failure Model (SHFM) for overall survival and the Seattle Proportional Risk Model (SPRM) for proportional risk of sudden death, including death from ventricular arrhythmias, would predict the survival benefit with an implantable cardioverter-defibrillator (ICD). METHODS Patients with primary prevention ICDs from the National Cardiovascular Data Registry (NCDR) were compared with control patients with heart failure (HF) without ICDs with respect to 5-year survival using multivariable Cox proportional hazards regression. RESULTS Among 98,846 patients with HF (87,914 with ICDs and 10,932 without ICDs), the SHFM was strongly associated with all-cause mortality (p < 0.0001). The ICD-SPRM interaction was significant (p < 0.0001), such that SPRM quintile 5 patients had approximately twice the reduction in mortality with the ICD versus SPRM quintile 1 patients (adjusted hazard ratios [HR]: 0.602; 95% confidence interval [CI]: 0.537 to 0.675 vs. 0.793; 95% CI: 0.736 to 0.855, respectively). Among patients with SHFM-predicted annual mortality <= 5.7%, those with a SPRM-predicted risk of sudden death below the median had no reduction in mortality with the ICD (adjusted ICD HR: 0.921; 95% CI: 0.787 to 1.08; p = 0.31), whereas those with SPRM above the median derived the greatest benefit (adjusted HR: 0.599; 95% CI: 0.530 to 0.677; p < 0.0001). CONCLUSIONS The SHFM predicted all-cause mortality in a large cohort with and without ICDs, and the SPRM discriminated and calibrated the potential ICD benefit. Together, the models identified patients less likely to derive a survival benefit from primary prevention ICDs. (J Am Coll Cardiol 2017;69:2606-18) (C) 2017 by the American College of Cardiology Foundation. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a heart failure | |
653 | a implantable cardioverter-defibrillator | |
653 | a risk models | |
653 | a cardiac-resynchronization therapy | |
653 | a primary prevention | |
653 | a prophylactic | |
653 | a implantation | |
653 | a ejection fraction | |
653 | a survival | |
653 | a mortality | |
653 | a death | |
653 | a trial | |
653 | a metaanalysis | |
653 | a association | |
653 | a Cardiovascular System & Cardiology | |
653 | a heart failure; implantable cardioverter-defibrillator; risk models | |
700 | 1 | a Wang, Y. F.u Yale New Haven Medical Centre, CT 06504 USA; Yale University, CT USA4 aut |
700 | 1 | a Cheng, A.u Johns Hopkins Medical Institute, MD 21205 USA4 aut |
700 | 1 | a Curtis, J. P.u Yale New Haven Medical Centre, CT 06504 USA; Yale University, CT USA4 aut |
700 | 1 | a Dharmarajan, K.u Yale New Haven Medical Centre, CT 06504 USA; Yale University, CT USA4 aut |
700 | 1 | a Stukenborg, G. J.u University of Virginia, VA USA4 aut |
700 | 1 | a Shadman, R.u Southern Calif Permanente Medical Grp, CA USA4 aut |
700 | 1 | a Anand, I.u University of Minnesota, MN USA4 aut |
700 | 1 | a Lund, L. H.u Karolinska Institutet4 aut |
700 | 1 | a Dahlström, Ulfu Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US4 aut0 (Swepub:liu)ulfda85 |
700 | 1 | a Sartipy, U.u Karolinska Institutet4 aut |
700 | 1 | a Maggioni, A.u Italian Assoc Hospital Cardiologists, Italy4 aut |
700 | 1 | a Swedberg, Karl,d 1944u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,University of Gothenburg, Sweden; Imperial Coll, England4 aut0 (Swepub:gu)xsweka |
700 | 1 | a O'Conner, C.u Inova Healthcare Syst, VA USA4 aut |
700 | 1 | a Levy, W. C.u University of Washington, WA USA4 aut |
710 | 2 | a University of Virginia Health Syst, VA USAb Yale New Haven Medical Centre, CT 06504 USA; Yale University, CT USA4 org |
773 | 0 | t Journal of the American College of Cardiologyd : Elsevier BVg 69:21, s. 2606-2618q 69:21<2606-2618x 0735-1097x 1558-3597 |
856 | 4 | u https://doi.org/10.1016/j.jacc.2017.03.568 |
856 | 4 8 | u https://gup.ub.gu.se/publication/254666 |
856 | 4 8 | u https://doi.org/10.1016/j.jacc.2017.03.568 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-138236 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:135854880 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.